Diamond Annual Review 2021/22

2 3 D I A M O N D L I G H T S O U R C E A N N U A L R E V I E W 2 0 2 1 / 2 2 D I A M O N D L I G H T S O U R C E A N N U A L R E V I E W 2 0 2 1 / 2 2 Foreword 2022 celebrates a double anniversary for Diamond - 20 years since the company was set-up to design, build and operate the UK’s national synchrotron and 15 years of delivering science and innovation to the science community. Diamond has made some considerable growth and leaps in this timeframe that have made a major contribution to science in general and the UK’s global leadership in this field. Indeed, the socio-economic study published in the past year highlighted a cumulative monetised impact of at least £1.8 billion from the impressive contribution of Diamond to UK science and the economy through ourmany strands of output including research, patents, software and applications, training, and our extensive programme of external engagement. The next exciting chapter for Diamond rests with the large upgrade Diamond-II programme. Budget pressures are felt everywhere but I believe that this investment in science is essential for the UK to move forward and cement its leadership position on the global stage. The board is committed to making the case to the Government on this basis and to fight for appropriate funding that secures our bright future for the next 20 years. Finally, the past years have not been easy, and I wanted on behalf of the entire Diamond board to thank everyone involved in delivering extremely valuable science as part of the response to the pandemic in challenging circumstances. Diamond has kept its doors open to researchers exploring a wide range of scientific endeavours. Diamond’s ongoing success is down to the outstanding people in all areas of the organisation. Professor Sir Adrian Smith Chairman of the Board of Directors The past years have not been easy, and I wanted on behalf of the entire Diamond board to thank everyone involved in delivering extremely valuable science as part of the response to the pandemic in challenging circumstances.